Local treatment of acute rhinosinusitis in the era of COVID-19

Author:

Krivopalov A. A.1ORCID,Ryazantsev S. V.1ORCID,Turieva V. V.1ORCID

Affiliation:

1. Saint Petersburg Research Institute of Ear, Throat, Nose and Speech

Abstract

   Introduction. Acute rhinosinusitis accounts for 40 % to 60 % of the morbidity in the structure of ENT pathology. COVID-19 pathogen, similarly to other respiratory viruses, can cause acute rhinosinusitis, which is the most relevant at the present time due to the ongoing pandemic. Viral etiology accounts for 90–98 % of all cases of acute rhinosinusitis. Accordingly, the choice of treatment tactics with antibacterial drugs in a number of cases is unreasonable and leads to the growth of antibiotic resistance. Local antiseptics containing sodium hypochlorite with a high safety profile that do not cause pathogen resistance are used to increase the effectiveness of therapy for acute rhinosinusitis.   Objective. To evaluate the effectiveness of nasal spray containing sodium hypochlorite on the duration of the course of exacerbation and severity of acute rhinosinusitis during the epidemiological season.   Materials and methods. The study involved 50 patients who were divided into 3 groups: 10 patients (group 1) with acute viral rhinosinusitis (therapy: sodium hypochlorite + decongestants); 20 patients (group 2) with acute bacterial rhinosinusitis (therapy: sodium hypochlorite + systemic antibacterial therapy); 20 patients (group 3) with acute bacterial rhinosinusitis (therapy: nasal lavage with isotonic sea salt solution + systemic antibacterial therapy).   Results and discussion. Pathogen eradication – the absence of the original pathogen at the locus of the inflammatory process during dynamic microbiological examination – was found in 14 (35 %) clinical cases: in Group 2 (sodium hypochlorite) – 10 (25 %) and in Group 3 (nasal irrigation with isotonic sea water solution) – 4 (10 %).   Conclusions. The results of microbiological studies showed effective antimicrobial properties of sodium hypochlorite when applied to the inflamed mucous membranes, expressed in a statistically significant reduction of bacterial semination of the nasal cavity epithelium.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference42 articles.

1. Derbeneva M. L., Guseva A. L. Acute rhinosinusitis: diagnosis and treatment. Consilium Medicum. 2018; 20 (3): 58-60. (In Russ.) URL: https://omnidoctor.ru/library/izdaniya-dlya-vrachey/consilium-medicum/cm2018/cm2018_3_pulmo/ostryy-rinosinusit-diagnostika-i-lechenie.

2. Ryazantsev S. V., Pavlova S. S., Donskaya O. S., Gorpinich V. D. Modern Approaches to the Treatment of Acute Sinusitis. Effective Pharmacotherapy. 2021; 17 (18): 40-45. URL: https://umedp.ru/upload/iblock/cb9/Pavlova.pdf.

3. Shisheva A. K., Korkmazov M. Yu. Socio-economic aspects hospital help optimization for patient with pathology of nose and paranasal sinuses in the large industrial city conditions. Vestnik Yuzhno¬ Uralskogo Gosudarstvennogo Universiteta. Seriya: Obrazovanie, Zdravookhranenie, Fizicheskaya Kultura. 2011; (26): 62-66. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=16922028.

4. Korkmazov M. Yu., Kornova N. V., Chin’kov N. A. The nature of cephalgia in acute and chronic sinusitis, their impact on the quality of life. Rossiiskaya Otorinolaringologiya. 2009; (2): 96-101. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=14565167.

5. Ryazantsev S. V., Fanta I. V., Pavlova S. S. Pathogenetic therapy of rhinosinusites in the practice of otorhinolaryngologist. Meditsinskiy Sovet. 2019; (6): 68-73. (In Russ.) https://doi.org/10.21518/2079-701X-2019-6-68-73.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3